AU2002333447A1 - Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity - Google Patents

Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity

Info

Publication number
AU2002333447A1
AU2002333447A1 AU2002333447A AU2002333447A AU2002333447A1 AU 2002333447 A1 AU2002333447 A1 AU 2002333447A1 AU 2002333447 A AU2002333447 A AU 2002333447A AU 2002333447 A AU2002333447 A AU 2002333447A AU 2002333447 A1 AU2002333447 A1 AU 2002333447A1
Authority
AU
Australia
Prior art keywords
prophylaxis
obesity
systems
treatment
producing drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002333447A
Other versions
AU2002333447B2 (en
Inventor
Martin Bickel
Matthias Gossel
Gerhard Jaehne
Volker Krone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10142659A external-priority patent/DE10142659A1/en
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of AU2002333447A1 publication Critical patent/AU2002333447A1/en
Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH
Application granted granted Critical
Publication of AU2002333447B2 publication Critical patent/AU2002333447B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002333447A 2001-08-31 2002-08-17 Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity Ceased AU2002333447B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10142659.3 2001-08-31
DE10142659A DE10142659A1 (en) 2001-08-31 2001-08-31 Use of multiply substituted indan-1-ol. Systems for the preparation of medicaments for the prophylaxis or treatment of obesity
PCT/EP2002/009200 WO2003020255A1 (en) 2001-08-31 2002-08-17 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity

Publications (2)

Publication Number Publication Date
AU2002333447A1 true AU2002333447A1 (en) 2003-06-05
AU2002333447B2 AU2002333447B2 (en) 2006-10-26

Family

ID=7697230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002333447A Ceased AU2002333447B2 (en) 2001-08-31 2002-08-17 Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity

Country Status (10)

Country Link
US (3) US6686397B2 (en)
EP (1) EP1425000B1 (en)
JP (1) JP2005507382A (en)
AU (1) AU2002333447B2 (en)
CA (1) CA2458553A1 (en)
DE (1) DE10142659A1 (en)
IL (1) IL160600A0 (en)
MX (1) MXPA04001847A (en)
PE (1) PE20030363A1 (en)
WO (1) WO2003020255A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142663B4 (en) 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituted indan-1-ol systems
DE10142661B4 (en) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Poly-substituted indan-1-ol systems and their use as pharmaceuticals
JP4774763B2 (en) * 2004-03-25 2011-09-14 住友化学株式会社 Method for producing purified 3-methyl-2-butenyl acetate
US20050238979A1 (en) * 2004-04-08 2005-10-27 Christophe Dumousseaux Compositions for application to the skin, to the lips, to the nails, and/or to hair
US20050257715A1 (en) * 2004-04-08 2005-11-24 Christophe Dumousseaux Compositions for application to the skin, to the lips, to the nails, and/or to hair
ATE442064T1 (en) * 2004-10-05 2009-09-15 Oreal MAKEUP KIT AND PROCEDURE
FR2876011B1 (en) * 2004-10-05 2006-12-29 Oreal METHOD FOR MAKE-UP A SUPPORT AND KIT FOR IMPLEMENTING SAID METHOD
US9649261B2 (en) 2004-10-05 2017-05-16 L'oreal Method of applying makeup to a surface and a kit for implementing such a method
KR100693528B1 (en) * 2004-10-29 2007-03-14 주식회사 팬택 Wireless communication terminal for delaying power on
FR2888115B1 (en) * 2005-07-08 2013-02-15 Oreal LIQUID FOUNDATION, MAKE - UP PROCESS AND KIT FOR IMPLEMENTING SUCH A METHOD.
FR2889921B1 (en) 2005-08-30 2007-12-28 Oreal CONDITIONING AND APPLICATION ASSEMBLY COMPRISING A MAGNETIC DEVICE.
DE102013009631A1 (en) * 2013-06-10 2014-12-11 Forschungszentrum Jülich GmbH Process for the preparation of cathin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2345146C3 (en) 1973-09-07 1981-08-06 Feinmechanische Werke Mainz Gmbh, 6500 Mainz Hydraulic actuator
FR2345146A1 (en) * 1976-03-23 1977-10-21 Logeais Labor Jacques Anorexigenic and lipolytic agent - contg. hydroxy-indanyl propanol for treating obesity
DE2965279D1 (en) * 1978-07-27 1983-06-01 Schering Ag Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
DE3103372A1 (en) * 1981-01-27 1982-09-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen NEW INDANYL DERIVATIVES, THEIR PRODUCTION AND USE
DE69629387T2 (en) * 1995-12-06 2004-06-24 Venantius Ltd. DIMERE INDAN COMPOUNDS AND THEIR PHARMACEUTICAL USE
HUP9902056A3 (en) 1996-01-17 2002-02-28 Novo Nordisk As Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
JP3149958B2 (en) 1996-08-30 2001-03-26 ノボ ノルディスク アクティーゼルスカブ GLP-1 derivative
PT958296E (en) 1996-12-31 2003-11-28 Reddys Lab Ltd Dr HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND ITS UTILIZATION IN THE TREATMENT OF RELATED DIABETES AND DISEASES
WO1999003861A1 (en) 1997-07-16 1999-01-28 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
US5987946A (en) 1997-08-15 1999-11-23 Watts; James A. Lock picking method and apparatus
FR2796070B1 (en) * 1999-07-06 2003-02-21 Lipha BENZODIAZEPINES DERIVATIVES FOR USE IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF PREPARATION
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
ATE283265T1 (en) * 2000-02-23 2004-12-15 Aventis Pharma Gmbh 8,8A-DIHYDRO-INDENO (1,2-D)THIAZOLE DERIVATIVES THAT ARE SUBSTITUTED IN THE 8A POSITION, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS, E.G. AS ANORECTIC AGENTS
DE10142662B4 (en) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivatives of C2-substituted indan-1-ol systems and their use as pharmaceuticals
DE10142661B4 (en) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Poly-substituted indan-1-ol systems and their use as pharmaceuticals

Similar Documents

Publication Publication Date Title
AU2003254038A1 (en) Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2003216592A1 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
AU2002258428A1 (en) Methods for the treatment of metabolic disorders, including obesity and diabetes
AU2002333447A1 (en) Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity
IL160600A0 (en) Use of polysubstituted indan-1-ol systems for the preparation of medicaments for the prophylaxis or treatment of obesity
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
AU2003224002A1 (en) Drugs for the arthritis treatment
AU2002237783A1 (en) Pillows for the physically disabled person
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU2002236781A1 (en) Treatment for snoring
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU3593599A (en) Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof
AU2003282626A1 (en) Use of flavonoid for the treatment of overweight and the reduction of the mammalian appetite
AU2002342615A1 (en) Use of derivatives of C2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity
AU2002315485A1 (en) Compositions and methods for the treatment of body weight disorders, including obesity
AU2002333448A1 (en) Derivatives of C2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
AU2002336984A1 (en) Use of C2-substituted Indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
AU2002336985A1 (en) Use of C2-substituted Indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
IL160607A0 (en) Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i